Literature DB >> 3457013

Isolated osteoclasts resorb the organic and inorganic components of bone.

H C Blair, A J Kahn, E C Crouch, J J Jeffrey, S L Teitelbaum.   

Abstract

Osteoclasts are the principal resorptive cells of bone, yet their capacity to degrade collagen, the major organic component of bone matrix, remains unexplored. Accordingly, we have studied the bone resorptive activity of highly enriched populations of isolated chicken osteoclasts, using as substrate devitalized rat bone which had been labeled in vivo with L-[5-3H]proline or 45Ca, and bone-like matrix produced and mineralized in vitro by osteoblast-like rat osteosarcoma cells. When co-cultured with a radiolabeled substrate, osteoclast-mediated mineral mobilization reached a maximal rate within 2 h, whereas organic matrix degradation appeared more slowly, reaching maximal rate by 12-24 h. Thereafter, the rates of organic and inorganic matrix resorption were essentially linear and parallel for at least 6 d when excess substrate was available. Osteoclast-mediated degradation of bone collagen was confirmed by amino acid analysis. 39% of the solubilized tritium was recovered as trans-4-hydroxyproline, 47% as proline. 10,000 osteoclasts solubilized 70% of the total radioactivity and 65% of the [3H]-trans-4-hydroxyproline from 100 micrograms of 25-50 micron bone fragments within 5 d. Virtually all released tritium-labeled protein was of low molecular weight, 99% with Mr less than or equal to 10,000, and 65% with Mr less than or equal to 1,000. Moreover, when the 14% of resorbed [3H]proline-labeled peptides with Mr greater than or equal to 2,000 were examined for the presence of TCA and TCB, the characteristic initial products of mammalian collagenase activity, none was detected by SDS PAGE. In addition, osteoclast-conditioned medium had no collagenolytic activity, and exogenous TCA and TCB fragments were not degraded by osteoclasts. On the other hand, osteoclast lysates have collagenolytic enzyme activity in acidic but not in neutral buffer, with maximum activity at pH 4.0. These data indicate that osteoclasts have the capacity to resorb the organic phase of bone by a process localized to the osteoclast and its attachment site. This process appears to be independent of secretion of neutral collagenase and probably reflects acid protease activity.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3457013      PMCID: PMC2114153          DOI: 10.1083/jcb.102.4.1164

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  23 in total

1.  Rodent peritoneal macrophages as bone resorbing cells.

Authors:  S L Teitelbaum; C C Stewart; A J Kahn
Journal:  Calcif Tissue Int       Date:  1979-07-03       Impact factor: 4.333

2.  Immunoreactive collagenase and bone resorption.

Authors:  C Francois-Gillet; J M Delaissé; Y Eeckhout; G Vaes
Journal:  Biochim Biophys Acta       Date:  1981-02-18

3.  Phagocytosing macrophages exclude proteins from the zones of contact with opsonized targets.

Authors:  S D Wright; S C Silverstein
Journal:  Nature       Date:  1984 May 24-30       Impact factor: 49.962

4.  The organic-inorganic relationships in bone matrix undergoing osteoclastic resorption.

Authors:  E Bonucci
Journal:  Calcif Tissue Res       Date:  1974

5.  Osteoclasts derived from haematopoietic stem cells.

Authors:  P Ash; J F Loutit; K M Townsend
Journal:  Nature       Date:  1980-02-14       Impact factor: 49.962

6.  Mechanism of osteoclastic bone resorption: a new hypothesis.

Authors:  J N Heersche
Journal:  Calcif Tissue Res       Date:  1978-11-10

7.  Mouse osteoblasts synthesize collagenase in response to bone resorbing agents.

Authors:  J K Heath; S J Atkinson; M C Meikle; J J Reynolds
Journal:  Biochim Biophys Acta       Date:  1984-11-06

8.  Purification and properties of rat uterine procollagenase.

Authors:  W T Roswit; J Halme; J J Jeffrey
Journal:  Arch Biochem Biophys       Date:  1983-08       Impact factor: 4.013

9.  Studies on the formation of collagen. I. Properties and fractionation of neutral salt extracts of normal guinea pig connective tissue.

Authors:  J GROSS
Journal:  J Exp Med       Date:  1958-02-01       Impact factor: 14.307

10.  Identification of osteoclast-specific monoclonal antibodies.

Authors:  M J Oursler; L V Bell; B Clevinger; P Osdoby
Journal:  J Cell Biol       Date:  1985-05       Impact factor: 10.539

View more
  52 in total

1.  When developmental biology meets human pathology.

Authors:  G Karsenty
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-08       Impact factor: 11.205

Review 2.  Tumour necrosis factor superfamily cytokines and the pathogenesis of inflammatory osteolysis.

Authors:  J Lam; Y Abu-Amer; C A Nelson; D H Fremont; F P Ross; S L Teitelbaum
Journal:  Ann Rheum Dis       Date:  2002-11       Impact factor: 19.103

3.  Avian osteoblast conditioned media stimulate bone resorption by targeting multinucleating osteoclast precursors.

Authors:  E M Greenfield; J I Alvarez; E A McLaurine; M J Oursler; H C Blair; P Osdoby; S L Teitelbaum; F P Ross
Journal:  Calcif Tissue Int       Date:  1992-10       Impact factor: 4.333

4.  Cytosolic pH regulation in mouse macrophages. Proton extrusion by plasma-membrane-localized H(+)-ATPase.

Authors:  H Tapper; R Sundler
Journal:  Biochem J       Date:  1992-01-01       Impact factor: 3.857

5.  Role of lysosomal and cytosolic pH in the regulation of macrophage lysosomal enzyme secretion.

Authors:  H Tapper; R Sundler
Journal:  Biochem J       Date:  1990-12-01       Impact factor: 3.857

6.  Regulation of sealing ring formation by L-plastin and cortactin in osteoclasts.

Authors:  Tao Ma; Kavitha Sadashivaiah; Nandakumar Madayiputhiya; Meenakshi A Chellaiah
Journal:  J Biol Chem       Date:  2010-07-22       Impact factor: 5.157

Review 7.  Osteoclasts: New Insights.

Authors:  Xu Feng; Steven L Teitelbaum
Journal:  Bone Res       Date:  2013-03-29       Impact factor: 13.567

8.  Inwardly rectifying potassium current in rabbit osteoclasts: a whole-cell and single-channel study.

Authors:  M E Kelly; S J Dixon; S M Sims
Journal:  J Membr Biol       Date:  1992-03       Impact factor: 1.843

9.  Inhibition of bone resorption in vitro by selective inhibitors of gelatinase and collagenase.

Authors:  P A Hill; A J Docherty; K M Bottomley; J P O'Connell; J R Morphy; J J Reynolds; M C Meikle
Journal:  Biochem J       Date:  1995-05-15       Impact factor: 3.857

10.  Bone matrix constituents stimulate interleukin-1 release from human blood mononuclear cells.

Authors:  R Pacifici; A Carano; S A Santoro; L Rifas; J J Jeffrey; J D Malone; R McCracken; L V Avioli
Journal:  J Clin Invest       Date:  1991-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.